Bank of New York Mellon »

Actuate Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2025-12-31 $77k 13k 6.12